Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Amifostine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mylan Lab’s Generic Amifostine Receives Approval In US
    Mylan Lab’s Generic Amifostine Receives Approval In US

    18 Jul 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204363

    FDA
    18 Jul 2017
    Share Share
    Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol
    Cumberland Pharmaceuticals Begins U.S. Shipments Of Ethyol

    23 Aug 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-begins-us-shipments-of-ethyol-amifostine-for-oncology-patient-support-300316919.html

    PR NEWSWIRE
    23 Aug 2016
    Share Share
    Cumberland Pharma & Clinigen Group enter into exclusive US commercial agreement
    Cumberland Pharma & Clinigen Group enter into exclusive US commercial agreement

    10 May 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-and-clinigen-group-enter-into-exclusive-us-commercialization-agreement-for-oncology-support-drug-ethyol-300265589.html

    PR NEWSWIRE
    10 May 2016
    Share Share